Mi Hwa Heo
-
- Cancer Immunotherapy and Biomarkers 3
-
- Lung Cancer Treatments and Mutations 4
- Brain Metastases and Treatment 3
- Gastric Cancer Management and Outcomes 3
- Renal cell carcinoma treatment 2
-
- Cancer Genomics and Diagnostics 4
-
- Radiopharmaceutical Chemistry and Applications 2
-
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Myung‐Ju AhnHansang LeeJin Seok AhnJin Young KimKeunchil ParkJong‐Mu SunSe‐Hoon LeeKeon Uk Park
- Journals
- Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (1 paper)BMC Cancer (1 paper)
- Partner nations
- South KoreaUnited States
In The Last Decade
Mi Hwa Heo
26 papers receiving 258 citations
Peers
Comparison fields: 5 of 50
- Oncology 148
- Pulmonary and Respiratory Medicine 99
- Pathology and Forensic Medicine 36
- Hepatology 14
- Cancer Research 26
Countries citing papers authored by Mi Hwa Heo
This map shows the geographic impact of Mi Hwa Heo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Hwa Heo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Hwa Heo more than expected).
Fields of papers citing papers by Mi Hwa Heo
This network shows the impact of papers produced by Mi Hwa Heo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Hwa Heo. The network helps show where Mi Hwa Heo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mi Hwa Heo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 6 | |
| 9 | 2020 | 3 | |
| 10 | 2018 | 3 | |
| 11 | 2017 | 15 | |
| 12 | 2017 | 13 | |
| 13 | 2017 | 7 | |
| 14 | 2017 | 1 | |
| 15 | 2017 | 23 | |
| 16 | 2017 | 44 | |
| 17 | 2017 | 6 | |
| 18 | 2017 | 3 | |
| 19 | 2017 | 14 | |
| 20 | 2016 | 15 |
About Mi Hwa Heo
Mi Hwa Heo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 28 papers that have together received 262 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (4 papers), Brain Metastases and Treatment (3 papers), Gastric Cancer Management and Outcomes (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Renal cell carcinoma treatment (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Oncology (148 citations), Pulmonary and Respiratory Medicine (99 citations) and Pathology and Forensic Medicine (36 citations). Mi Hwa Heo has collaborated with scholars based in South Korea and United States. Frequent co-authors include Myung‐Ju Ahn, Hansang Lee, Jin Seok Ahn, Jin Young Kim, Keunchil Park, Jong‐Mu Sun, Se‐Hoon Lee, Keon Uk Park, Kang-Kook Lee and Hee Kyung Kim. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.